Journal
AMERICAN JOURNAL OF HYPERTENSION
Volume 16, Issue 2, Pages 135-139Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0895-7061(02)03203-X
Keywords
hypertension; nabumetone; angiotensin converting enzyme inhibitor; celecoxib
Categories
Ask authors/readers for more resources
Nonsteroidal anti-inflammatory drugs interfere with certain antihypertensive therapies. In a double-blind study, 385 hypertensive patients stabilized on an angiotensin converting enzyme inhibitor were treated with nabumetone, celecoxib, ibuprofen, or placebo for 4 weeks. Ibuprofen caused significantly greater increases in systolic (P < .001) and diastolic (P < .01) blood pressures (BPs) compared to placebo, but not nabumetone or celecoxib. The proportion of patients with systolic BP increases of clinical concern at end point was significantly higher (P < .001) for the ibuprofen group (16.7%; 15 of 90), but not for the nabumetone group (5.5%; 5 of 91) or the celecoxib group (4.6%; 4 of 87) compared to the placebo group (1.1%; 1 of 91). (C) 2003 American Journal of Hypertension, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available